Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid and Vitamin K for UGIB in Cirrhosis
NCT06881628Phase 4Recruiting
- Sponsor
- Tanta University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in upper gastrointestinal bleeding (UGIB) comparing Tranexamic acid + Vitamin K with Placebo (2 arms). Primary endpoint: Rebleeding rate at 1 year. Started Dec 2024; status: recruiting.
02
Drugs
tranexamic acidphytomenadione
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT06881628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06881628.